Your Success is our Success
Mobius Medical is a top tier, full service clinical research partner offering a customized service with unparalleled responsiveness. Owner operated, Mobius has operations throughout the United States, Australia and New Zealand, and staff based globally.
With a well-established, ISO:9001-certified Quality Management System, you can rely on our comprehensive standard operating procedures and processes.
“Better Together”
Mobius has a 15 year strong, proven track record for delivering a top class service for our clients, working closely with key stakeholders every step of the way
Our people are our greatest asset. Mobius prides itself on a long-term team of talented, caring professionals. Staff retention is crucial to us.
Full service or a la carte – our flexible approach is one that will be tailored to your exact needs, no matter the size of your project.
What they Say About Mobius
Mobius personnel have been responsive and professional with a clear demonstration of their experience conducting high quality research in compliance with applicable regulations and guidance
Mobius staff have been supporting our trial for the past year and a half. They have very capably handled ongoing interactions with the site coordinator(s) to ensure completion of key tasks. During the pandemic Mobius found and secured local NZ CRAs. This was incredible while much of the rest of world had to stop their trials, we were able to keep going.
[Mobius] have shown their ability to engage and maintain excellent working relationships with site personnel to ensure that work is completed accordingly to Sponsor deadlines
Through fantastic site management, Mobius was able to close and lock the study in record time, a crucial factor in the success of our company.Â
Selecting this team [Mobius] for the job was an inspired choice.
Mobius Medical has performed monitoring, project management, have built clinical databases and are a ‘go to’ expert in the clinical research field. They have been an extreme pleasure to work with, and our sites like working with them too
Mobius Medical has a clear understanding of clinical research and the regulatory bodies. Their monitoring has been thorough, while developing professional long-standing working relationships, and have kept the projects on track. I trust working with Mobius Medical and look forward to working on future projects with them
Mobius Medical have been a pleasure to work with. Their staff are reliable, they have solutions for nearly every query and have a range of experience being able to support from conception through to closeout. I have no hesitation recommending Mobius and will continue to work with their team as our own clinical development grows.
Responsive, tailoring [their] approach and support to our specific circumstances. [Mobius] are aware of, and work within our budget limitations, providing genuine recommendations on essential services while offering a high-quality service.
Mobius has been a trustworthy partner. We appreciate the lack of turnover and the consistency that provides to us, and our sites.
Consider Australia
Choose Mobius Medical
Local Sponsor
Therapeutic Goods Administration (TGA)Â mandates that an Australian entity sponsors ALL clinical trials.
Mobius acts as local Australian sponsor on behalf of our overseas clients.
This responsibility includes:
- Contractual arrangements for sites
- Indemnity, site payments
- Safety reporting responsibility to TGA
Speed of Start up
Australia’s TGA operates an expeditious on-line notification scheme, following approvals from ethics committee and local institution (or health authority).
Medical device trials are not regulated in New Zealand and only ethics/institutional approval are required.
Pharma studies do require NZ regulatory approval from SCOTT.
Cost Savings
Mobius works diligently to deliver nimble, efficient services that save time and money for our clients. Our EDC, and supplementary options such as ePRO/dairy, IWRS is built in-house saving our clients costs associated with EDC vendors.
Clinical trials conducted in Australia are fully eligible for the Australian R+D tax program which provides cash rebates of up to 43c for each $ spent.